RecruitingNCT06934499

Tunisian Lung Cancer Study

Clinical Observational Study on Tunisian Lung Cancer


Sponsor

Dacima Consulting

Enrollment

1,334 participants

Start Date

May 2, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This is a prospective, multicenter, observational, national study. Eligible patients will be recruited consecutively among subjects with proven lung cancer, including any disease stage withclinical, therapeutic and evolutive discription.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is an observational study collecting data on lung cancer patients in Tunisia. It aims to understand the characteristics, treatment patterns, and outcomes of lung cancer in this population — helping to improve care locally and contribute to a broader understanding of lung cancer in North Africa. **You may be eligible if...** - You have been diagnosed with lung cancer in Tunisia - You are being treated at a participating hospital or cancer center - You are an adult willing to have your medical information collected **You may NOT be eligible if...** - You do not have a confirmed lung cancer diagnosis - You decline to have your data used for research - You are receiving treatment outside of participating centers Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(2)

Tunisian Society of Medical Oncology

Aryanah, Tunisia

Tunisian Society of Respiratory Diseases and Allergology

Tunis, Tunisia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06934499


Related Trials